SH2B1 gene defends against obesity via the paraventricular hypothalamus

FHS
July 15, 2024
7:38 pm

Obesity is a complicated condition, caused by a combination of genetics, the food environment, behavior, and other factors.

Verona prepares for US launch of ensifentrine for COPD

Verona Pharma has announced that it is finalising preparations for the potential US launch of ensifentrine in the third quarter (Q3) of 2024, dependent upon

May 29, 2024

Risk Adjusted Net Present Value: What is the current valuation of Pfizer’s Atirmociclib

The revenue for Atirmociclib is expected to reach an annual total of $388 mn by 2040 globally based off GlobalData’s Revenue Model. The drug’s revenue

July 2, 2024

GTI Q1 Revenue Slips 4% Sequentially to $248.5 Million

Green Thumb Industries Reports First Quarter 2023 Results CHICAGO and VANCOUVER, British Columbia, May 03, 2023 (GLOBE NEWSWIRE) — Green Thumb Industries Inc. (“Green Thumb”

May 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.